Clinical and Hematological Profile of Patients with Dengue Fever at a Tertiary Care Hospital – An Observational Study
1 Assistant Professor, Department of Anesthesiology and Critical Care1, Base Hospital, New Delhi.
2 Associate Professor, Department of Pediatrics2, Army Hospital (Referral & Research), New Delhi.
3 Assistant Professor, Department of Pathology3, Base Hospital, New Delhi.
Received: January 10, 2018
Accepted: February 5, 2018
Mediterr J Hematol Infect Dis 2018, 10(1): e2018021 DOI 10.4084/MJHID.2018.021
This article is available on PDF format at:
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Dengue is a major health issue with seasonal rise in dengue fever cases
imposing an additional burden on hospitals, necessitating bolstering of
services in the emergency department, laboratory with creation of
additional dengue fever wards.
Material and Methods
|Figure 1. Age distribution of Pediatric case.|
patients (337/500; 67.4%) while in 37 patients (37/500; 7.4%) the IgM antibody was negative but they showed positivity for IgG antibody. In 11 patients (11/500; 2.2%) initial sample was negative for NS1 antigen test but IgM antibody test done two to five days later was positive. The commonest presenting complaint was fever (99.8%) with severe arthralgia and myalgia (97.4%). Other symptoms were loose motions (12.6%), rashes (45.8%), vomiting (10.2%), breathlessness (1.6%), headache (47%), retro-orbital pain (65%) and abdominal pain (11.8%). Breathlessness was seen in 8 patients (1.6%) all of whom had serositis. DF was diagnosed in 429 cases (429/500; 85.8 %), DFWS in 55 cases (55/500; 11%), SD with severe bleeding in 10 (10/500; 2%) and SD with severe plasma leakage in 6 cases (6/500; 1.2%) (Table 1). Four hundred and twelve cases (412/500; 82%) were treated as outpatients while 88 patients (88/500; 18%) required admission. All 55 cases of DFWS, 10 patients of SD with severe bleeding, 6 patients of SD with severe plasma leak, all 4 pregnant patients and 13 children were hospitalized. Mild dehydration was noted in 179 patients of DF (179/484; 36.9%) who were treated with oral rehydration therapy, while 45 cases of DFWS (45/484; 9.3%) required intravenous fluid therapy. Sixteen patients (16/490; 3.2%) had severe dehydration requiring IV fluid resuscitation of which 10 cases were of DFWS and 6 were of SD with severe plasma leak (Table 2). Thrombocytopenia was seen in 335 (335/500; 67%) patients while increased hematocrit was seen in 66 (66/500; 13.2%) patients at the time of presentation (Table 1). Bleeding manifestations were seen in 36 patients of DFWS (36/55; 65.4%). Out of these 27 patients had petechiae, 4 patients had epistaxis, 3 had hematemesis and 2 had melena. Amongst these, 10 patients had platelet count < 10,000/cu.mm, 23 patients had platelet count was between 11-20,000/cu.mm while in 3 patients the platelet count was between 21-30,000/cu.mm (Table 3). Platelet transfusions were given in all 36 cases. PRBC transfusion was required in 3 patients with DFWS with hemoglobin < 8.5 gm/dl and 10 patients with SD with severe bleeding. All 10 patients with SD with severe bleeding required platelet transfusions. Three patients of SD with severe plasma leak and 2 patients of SD with severe bleeding died. There was no mortality in the pediatric cases or the pregnant women.
|Table 1. Demographic and clinical characteristics of patients enrolled in the study.|
|Table 2. Treatment and outcome details of the admitted patients.|
|Table 3. Correlation of thrombocytopenia with bleeding manifestation and number of cases in Dengue fever patients.|
|Table 4. Duration of hospitalization with different indications.|
Appropriate timing of NS1 antigen test is important. We performed NS1 antigen testing in patients presenting within 5 days of onset of symptoms in order to reliably identify cases of primary dengue infection as well as secondary dengue infection also in which the NS1 antigen test remains positive for a shorter time frame. There were 11 (2.2%) patients in whom the NS1 antigen test turned out to be negative but were later confirmed to be dengue IgM antibody test positive. We used the one-step immunochromatographic assay for IgM and IgG antibody testing which identifies acute as well as past dengue infections with excellent sensitivity and specificity. There were 37 (7.4%) patients in whom the IgM antibody was negative but IgG antibody was positive. These patients were cases of secondary dengue infection which were confirmed by a ≥ 4 fold elevation in the IgG antibody titres by enzyme-linked immunosorbent assay (IgG-ELISA) in the convalescent serum sample at follow-up done at a reference laboratory. Out of these 37 patients, 4 had DFWS requiring hospitalization but none had SD. The 11 (2.2%) patients in whom the NS1 antigen test was negative were cases of acute infection confirmed by IgM antibody testing who presented more than five days since onset of fever which explains the initial negative NS1 antigen test.
The use of NS1 antigen test, IgM and IgG antibody testing for diagnosis of dengue infection can show false positivity due to cross reaction with other flaviviral infections. We did not use real-time polymerase chain reaction (RT-PCR) for viral RNA detection for diagnosis due to feasibility issues and these are the limitations of our study. The strength of this study is the inclusion of serologically confirmed cases, inclusion of patients of all age groups and threadbare clinical and hematological profile of the enrolled cases, which can help guide local health authorities on resource allocation for capacity expansion. This is a single center experience and since our hospital serves a specific clientele (armed forces personnel, in active service or retired and their dependents), this is a limitation of this study. However this should not affect its external validity and the generalizability of its findings.
Several outbreaks of DF have been reported over the past 2 decades[17-23] and a seasonal trend during the monsoon period has been noted due to the warm environment and high relative humidity favoring vector growth. The reported case fatality rate shows a declining trend from 6-9%[17,18,27] to 0% attributable to increased awareness and better case diagnosis and management. There has been increasing atypical and rare presentations of DF resulting in the expanded dengue definition.[28,29] Some studies similar to ours from other parts of the country have reported significant differences in the incidence of atypical presentation like neurological signs or the incidence of serositis[11,12] while others have reported similar findings. These differences may be due to co-infection with other pathogens or secondary heterotypic dengue virus infections. Dengue is grossly underreported in our country. The WHO estimates that nearly 5 lac people are admitted with dengue in our country annually and that India accounts for nearly 20% of all cases in the south-east Asian region (SEAR).
- Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002; 33(4): 330-42. https://doi.org/10.1016/S0188-4409(02)00378-8
- Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature 2013; 496:504-7. https://doi.org/10.1038/nature12060 PMid:23563266 PMCid:PMC3651993
- Chaudhuri M. What can India do about dengue fever? BMJ 2013; 346: f643. doi:10.1136/bmj.f643 https://doi.org/10.1136/bmj.f643
- Simmons CP, Farrar JJ, Chau NV, Wills B. Dengue. N Engl J Med 2012; 366:1423-32. https://doi.org/10.1056/NEJMra1110265 PMid:22494122
- World Health Organization. Dengue guidelines for diagnosis, treatment, prevention and control. 2009. http://whqlibdoc.who.int/publications/2009/9789241547871eng.pdf [accessed 15 Nov 2017]
- Amin P, Acicbe O, Hidalgo J, Jimenez JIS, Baker T, Richards GA. Dengue fever: report from the task force on tropical diseases by the world federation of societies of intensive and critical care medicine. J Crit Care 2017. https://doi.org/10.1016/j.jcrc.2017.11.003
- Guzman MG, Kouri G. Dengue: an update. Lancet Infect Dis 2002; 2(1): 33-42. https://doi.org/10.1016/S1473-3099(01)00171-2
- Kouri GP, Guzman MG, Bravo JR. Why dengue haemorrhagic fever in Cuba? 2: an integral analysis. Trans R Soc Trop Med Hyg 1987; 81: 821–23. https://doi.org/10.1016/0035-9203(87)90042-3
- Basheer A., Iqbal N., Mookkappan S., Anitha P., Nair S., Kanungo R., Kandasamy R. Clinical and laboratory characteristics of dengue-orientia tsutsugamushi co-infection from a tertiary care center in south india. Mediterr J Hematol Infect Dis 2016, 8(1): e2016028 https://doi.org/10.4084/mjhid.2016.028
- Gupta N, Srivastava S, Jain A, Chaturvedi UC. Dengue in India. Indian J Med Res 2012; 136: 373-90. PMid:23041731 PMCid:PMC3510884
- Karoli R, Fatima J, Siddiqi Z, Kazmi KI, Sultania AR. Clinical profile of dengue infection at a teaching hospital in North India. J Infect Dev Ctries 2012; 6(7):551-54. https://doi.org/10.3855/jidc.2010 PMid:22842941
- Mandal SK, Ganguly J, Sil K, Chatterjee S, Chatterjee K, Sarkar P, et al. Clinical profiles of dengue fever in a teaching hospital of eastern India. Nat J Med Res 2013; 3(2) 173-76.
- Roy MP, Gupta R, Chopra N, Meena SK, Aggarwal KC. Seasonal Variation and Dengue Burden in Paediatric Patients in New Delhi. J Trop Pediatr 2017. https://doi.org/10.1093/tropej/fmx077
- Pal S, Dauner AL, Mitra I, Forshey BM, Garcia P, Morrison AC, et al. Evaluation of Dengue NS1 Antigen Rapid Tests and ELISA Kits Using Clinical Samples. PLoS ONE 2014; 9(11): e113411. https://doi.org/10.1371/journal.pone.0113411
- Wang SM, Sekaran SD. Early diagnosis of dengue infection using a commercial dengue duo rapid test kit for the detection of NS1, IGM and IGG. Am J Trop Med Hyg 2010; 83(3):690-5. https://doi.org/10.4269/ajtmh.2010.10-0117 PMid:20810840 PMCid:PMC2929071
- Zammarchi L., Spinicci M., Bartoloni A. Zika virus: a review from the virus basics to proposed management strategies. Mediterr J Hematol Infect Dis 2016; 8(1): e2016056, doi: https://doi.org/10.4084/mjhid.2016.056
- Anuradha S, Singh NP, Rizvi SN, Agarwal SK, Gur R, Mathur MD. The 1996 outbreak of dengue hemorrhagic fever in Delhi, India. Southeast Asian J Trop Med Public Health 1998; 29(3): 503-6. PMid:10437946
- Kabra SK, Jain Y, Pandey RM, Madhulika, Singhal T, Tripathi P, et al. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 1999; 93(3): 294-8. https://doi.org/10.1016/S0035-9203(99)90027-5
- Singh NP, Jhamb R, Agarwal SK, Gaiha M, Dewan R, Daga MK, et al. The 2003 outbreak of Dengue fever in Delhi, India. Southeast Asian J Trop Med Public Health 2005; 36(5): 1174-8. PMid:16438142
- Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, et al. Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India. Virol J 2008; 5:1. https://doi.org/10.1186/1743-422X-5-1
- Jhamb R, Kumar A, Ranga GS, Rathi N. Unusual manifestations in dengue outbreak 2009, Delhi, India. J Commun Dis 2010; 42(4): 255-61. https://doi.org/10.1016/S1201-9712(10)60301-3
- Jain S, Sharma SK. Challenges & options in dengue prevention & control: A perspective from the 2015 outbreak. Indian J Med Res 2017; 145: 718-21. PMid:29067972 PMCid:PMC5674540
- Laul A, Laul P, Merugumala V, Pathak R, Miglani U, Saxena P. Clinical Profiles of Dengue Infection during an Outbreak in Northern India. J Trop Med 2016; Article ID 5917934. https://doi.org/10.1155/2016/5917934
- Dar L, Broor S, Sengupta S, Xess I, Seth P. The First Major Outbreak of Dengue Hemorrhagic Fever in Delhi, India. Emerg Inf Dis 1999; 5(4): 589-90. https://doi.org/10.3201/eid0504.990427 PMid:10458971 PMCid:PMC2627747
- Roy MP, Gupta R, Chopra N, Meena SK, Aggarwal KC. Seasonal Variation and Dengue Burden in Paediatric Patients in New Delhi. J Trop Pediatr 2017; https://doi.org/10.1093/tropej/fmx077
- Chakravarti A, Arora R, Luxemburger C. Fifty years of dengue in India. Trans R Soc Trop Med Hyg 2012; 106:273-82. https://doi.org/10.1016/j.trstmh.2011.12.007 PMid:22357401
- Aggarwal A, Chandra J, Aneja S, Patwari AK, Dutta AK. An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi. Indian Pediatr 1998; 35(8):727-32. PMid:10216566
- Kadam DB, Salvi S, Chandanwale A. Expanded dengue. J Assoc Physicians India 2016; 64(7):59-63. PMid:27759344
- Tansir G, Gupta C, Mehta S, Kumar P, Soneja M, Biswas A. Expanded dengue syndrome in secondary dengue infection: A case of biopsy proven rhabdomyolysis induced acute kidney injury with intracranial and intraorbital bleeds. Intractable Rare Dis Res 2017; 6(4):314-18. https://doi.org/10.5582/irdr.2017.01071 PMid:29259863 PMCid:PMC5735288
- Halstead SB. Dengue. Lancet 2007; 370:1644–52. https://doi.org/10.1016/S0140-6736(07)61687-0
- Kakkar M. Dengue fever is massively under-reported in India, hampering our response. BMJ 2012; 345:e8574. doi:10.1136/bmj.e8574. https://doi.org/10.1136/bmj.e8574
- World Health Organization (WHO). 2013. Dengue and severe dengue: Fact sheet No. 117. Available from: http://www.who.int/mediacentre/factsheets/fs117/en/, [accessed on 15 Nov 2017].
Metrics powered by PLOS ALM
Copyright (c) 2018 Mediterranean Journal of Hematology and Infectious Diseases
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.